⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RXRX News
Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
globenewswire.com
RXRX
RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry
prnewswire.com
BIIB
REGN
GILD
BTE
BROS
BFLY
BCTX
BCRX
BTAI
ALRS
CAPR
CRIS
CYCN
EXAS
FATE
GNTX
HRMY
INCY
IONS
KODK
LAKE
LULU
MRNA
NBIX
NTRA
OCGN
ORGN
PGEN
PLRX
RARE
RGNX
RXRX
SAVA
SGMO
SNOW
SRPT
STEM
TGTX
TLSA
TXG
VRTX
ZETA
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
prnewswire.com
AMD
HYFT
RXRX
ABSI
TEM
NVDA
Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and Development
globenewswire.com
GOOG
NVDA
IBM
RXRX
Generative AI Drives Revolutionary Changes in Healthcare: Key Trends and Opportunities
globenewswire.com
MSFT
INTC
NVDA
IBM
VRSN
GOOG
RXRX
EXEL
ATOM
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data
prnewswire.com
ABCL
HYFT
SDGR
RXRX
TEM
A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs
prnewswire.com
CMPX
NKTX
GTBP
RXRX
FATE
Form 8-K
sec.gov
RXRX
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
prnewswire.com
HYFT
SDGR
RXRX
ABSI
CERT
Recursion to Participate in Upcoming Investor Conferences
globenewswire.com
RXRX